NCT05123729 · Wake Forest University Health Sciences
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
What this study is about
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
View original scientific description
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
Interventions
BEHAVIORAL
Crowdsourced campaign package
Disease prevention intervention developed using a crowdsourcing process.
BEHAVIORAL
Rapid Response Teams
Pilot a new hybrid training focused on contact tracing and case investigation.
Primary outcome measures
Number of participants enrolled as measured by enrollment log
Time frame: Up to 3 years
Number of participants enrolled as measured by enrollment log
Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire
Time frame: Up to 4 years
Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- All individuals aged 18+ years are eligible for study participation. Each phase may have additional requirements, including residency in North Carolina, employment at a local health department, etc. Participants must be able to complete study activities independently and have the capacity to consent to study participation.
Where
- Winston-Salem, North Carolina
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 16, 2026 · Source of record for eligibility and locations